ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

UCLA Comp Center status Near, But There Are Problems

October 22, 1976

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989

Sole Source Negotiations

October 17, 1975